Skip to main content
. Author manuscript; available in PMC: 2022 Jul 4.
Published in final edited form as: Ocul Immunol Inflamm. 2020 Aug 19;29(5):1029–1031. doi: 10.1080/09273948.2020.1784439

Table 1.

Mass Spectrometry Analysis of Vitreous Specimens

Heavy Metal Patient Vitreous Concentration* (mcg/L) Control Vitreous Concentration** (mcg/L) Measurement Standard Deviation (mcg/L) Patient / Control (%)
Titanium 623844.5 20.3 ± 6.3 3073026
Chromium 1582.7 14.5 ± 0.5 10815
Nickel 833.1 8.2 ± 1.0 10060
Manganese 177.9 4.1 ± 0.1 4239
Arsenic 98.3 0.4 ± 0.1 24475
Copper 58.3 0.5 ± 0.0 12856
Cobalt 25.5 0.7 ± 0.1 3543
Selenium 22.0 11.2 ± 1.1 96
Zinc 12.2 2.3 ± 0.3 431
Antimony 9.3 7.5 ± 1.8 24
Lead 3.0 0.2 ± 0.1 1400
Mercury 0.4 0.2 ± 0.0 100
Cadmium 0.2 0.0 ± 0.0 N/A
Beryllium 0.0 0.0 ± 0.0 N/A
Thallium 0.0 0.0 ± 0.0 N/A
*

Heavy metal concentrations in a vitreous cavity aspirate specimen from this scleral tattoo patient.

**

Heavy metal concentrations in a vitreous cavity aspirate specimen from an age-matched normal control patient.